Merck Other Current Liab from 2010 to 2024

0QAH Stock  USD 103.50  27.80  21.17%   
Merck Other Current Liabilities yearly trend continues to be quite stable with very little volatility. The value of Other Current Liabilities is projected to decrease to about 4.3 B. From the period between 2010 and 2024, Merck, Other Current Liabilities regression line of its data series had standard deviation of  698,544,845 and standard deviation of  698,544,845. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
B
Current Value
4.3 B
Quarterly Volatility
698.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Discontinued Operations of 601.9 M, Ebit of 11.8 B or Net Income Applicable To Common Shares of 11 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
This module can also supplement various Merck Technical models . Check out the analysis of Merck Correlation against competitors.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out the analysis of Merck Correlation against competitors.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.